LONG-TERM RESULTS OF COMBINED TREATMENT OF METASTASES OF SARCOMA OF THE MUSCULOSKELETAL SYSTEM IN THE LUNGS
https://doi.org/10.18027/2224-5057-2014-3-48-51
Abstract
From 2004 to 2014 forty-six patients with sarcomas of the musculoskeletal system with metastatic lesions in the lungs were operated in MRRC. In 22 patients with a primary bone sarcoma metastases were detected in 27% cases, and in 29% of 24 patients with soft tissue sarcomas metastases were identified at the time of diagnosis. Twenty women and twenty-six men aged 16 to 72 years (mean age was 39 years) were operated. In most cases metastases were located subpleurally. Solitary metastases were observed in 8 patients (17%), single in 11 (24%) and multiple in 27 (68%) and 18 patients of them had bilateral disease. In all cases, chemotherapy was conducted at the first stage of treatment, according to histology of the tumor. In cases of large metastases or close location to the root of the lung (27 patients) preoperative distal radiotherapy was conducted in hyperfraction regimen with a daily dividing of the dose (2 times a day with an interval of 4 h every other day with single dose of 3 Gy and the total dose of 30 Gy that was isoefficiency to 42 Gy), after that the removal of pulmonary metastases was performed. A total of 73 surgical interventions performed in 46 patients. Most often precision resection of the lung using a neodymium YAG surgical laser MY 40 (wavelength 1318 nm) was performed. One patient underwent pneumonectomy. Videothoracoscopy was used in 6 cases. From 1 to 103 metastases were excised during one intervention. Pneumonia with abscesses were diagnosed in 3 patients, persistent pneumothorax in 5 patients, all complications were treated conservatively. There was no postoperative mortality. Fourteen patients underwent 2 procedures, two patients – 3 procedures, two patients – 4 procedures and one patient had 6 procedures. Follow-up ranged from 3 to 126 months. Twenty-six patients died due to progression of the disease. 3-year and 5-year survival was 46% and 41% respectively. Median survival was 32 months. Thus, the combined treatment of generalized forms of sarcomas of the musculoskeletal system can achieve long-term remission and significantly prolong life. Surgical resection should be applied in patients with solitary and with multiple metastases in the lungs and should be combined with systemic treatment (PCT) and, if indicated, with additional local treatment (distant radiotherapy) of metastases. Precision resection is adequate and well-tolerated method of surgical treatment of metastases in the lungs and does not correlate with severe postoperative complications.
About the Authors
Aleksei L. StarodubtsevRussian Federation
Yuri A. Ragulin
Russian Federation
Aleksandr A. Kurilchik
Russian Federation
Aleksei L. Zubarev
Russian Federation
Vyacheslav E. Ivanov
Russian Federation
Vladimir S. Usachev
Russian Federation
Fedor V. Medvedev
Russian Federation
References
1. Ахмедов Б. П. Метастатические опухоли. – М.: Медицина, 1984.
2. Пирогов А. И., Смулевич В. Б. Повторные оперативные вмешательства по поводу метастатических опухолей легких // Хирургия. – 1967. – № 9. – С. 32–35.
3. Поддубный Б. К. Хирургическое лечение солитарных метастатических опухолей легких: Дис. канд. мед. наук. – М., 1969.
4. Самсонов В. А. Метастазы рака почки (по данным аутопсий) // Вопросы онкологии.– 1986.– № 32.– С.78–81.
5. Чиссов В. И., Трахтенберг А. Х., Пикин О. В., Паршин В. Д. Метастатические опухоли легких // М: Гоэтар-Медиа – 2009. – С. 101–109.
6. Antunes M., Bernardo J., Salete M., Prieto D., Eugenio L., Tavares P. Excision of pulmonary metastases of osteogenic sarcoma of the limbs // Eur J Cardiotthorac Surg. – 1999. – Vol.15. –№ 5. – P.592–596.
7. Billingsley K. G., Burt M. E., Gara E., Ginsberg R. J., Woodruff J. M. Pulmonary metastases of soft tissue sarcoma: analyses of patterns diseases and postmetastases survival // Ann Surg. – 1999. – Vol. 229. – № 5. – P. 602–610.
8. Bricolli A., Ferrari S., Picci P. et al. Surgical treatment of pulmonary metastases of osteosarcoma. Apropos of 206 operated cases // Ann Chir.–1999.– Vol.53.– № 3.– p.207–214.
9. Bricolli A., Rocca., Ferrari S. et al. Surgery for lung metastases in Ewings sarcoma of bone // Eur J Surg Oncol. –2004. – Vol. 30. – № 1. – P.63–67.
10. Bross & Blumenson // Oncology. – 1976. – V.12. – P.538–542.
11. Ellis P. V., Tattersall M. H., McCaughan B., Stalley P. Osteosarcoma and pulmonary metastases: a 15-year experience from a single institution // Aust N Z J Surg. –1997. – Vol. 67. –№ 9/P.625–629.
12. Greelish J., Friedberg J. Secondary pulmonary malignancy // Surg Clin N Am., 2000.– Vol. 80.– № 2.– P.633–657.
13. van Geel AN., Pastorino U., Jauch KW. et al Surgical treatment of lung metastases: the European Organization for research and treatment of cancer – soft tissue and bone sarcoma group study of 255 patients // Cancer. – 1996/ Vol.77. – № 4. – P.675–682.
14. Muller K. M. Pulmonary metastases. Patological anatomy // Thorac and Cardiovasc. Sur. – 1986.– V.34.– P.115–119.
15. Nielsen O. Role of systemic treatment in adult soft tissue sarcomas // Eur. J. Cancer Suppl.– 2003.– Vol. 1.– № 6.– p. 249–259.
16. Piacenza G., Mantellini E., Cremonte L. G., Salio M. Metastasi Endobronchiali isolate // G. Chir.– 1986.– V.7.– P.1330–1332.
17. Vogt-Myokopl I., Meyer J., Bulzebruck H. Lungmetastasen, Therapieindication und chirurgiche. Munch. med. Wochensschr. – 1986.– V.128.– P.295–300.
18. Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer WH, Link MP. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J ClinOncol 1991; 9:600–5.
19. Huth JF, Eilber FR. Patterns of recurrence after resection of osteosarcoma of the extremity. Strategies for treatment of metastases. Arch Surg1989;124:122–6.
20. Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, LaQuagliaM. Osteogenic sarcoma with clinically detectable metastasis at initialpresentation. J ClinOncol 1993;11:449–53.
21. Sternberg DI, Sonett JR. Surgical therapy of lung metastases. SeminOncol2007;34:186–96.
22. van Geel AN, Pastorino U, Jauch KW, Judson IR, van Coevorden F, BuesaJM, Nielsen OS, Boudinet A, Tursz T, Schmitz PI. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer1996;77:675–82.
23. van Geel AN, van CF, Blankensteijn JD, Hoekstra HJ, Schuurman B, Bruggink ED, Taat CW, Theunissen EB. Surgical treatment of pulmonary metastases from soft tissue sarcomas: a retrospective study in The Netherlands. J SurgOncol 1994;56:172–7.
24. Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, Brennan MF. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:602–10.
25. Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtreyM, Roth JA. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662–8.
26. Bacci G, Briccoli A, Longhi A, Ferrari S, Mercuri M, Faggioli F, Versari M, Picci P. Treatment and outcome of recurrent osteosarcoma: experience atRizzoli in 235 patients initially treated with neoadjuvant chemotherapy. ActaOncol 2005;44:748–55.
27. van VM, Kliffen M, Krestin GP, van Dijke CF. Soft tissue sarcomas at a glance: clinical, histological, and MR imaging features of malignant extremity soft tissue tumors. EurRadiol 2009;19:1499–511.
28. Chen F, Fujinaga T, Sato K, Sonobe M, Shoji T, Sakai H, Miyahara R, BandoT, Okubo K, Hirata T, Date H. Significance of tumor recurrence beforepulmonary metastasis in pulmonary metastasectomy for soft tissue sarcoma.Eur J SurgOncol 2009;35:660–5.
29. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50patients. ThoracCardiovascSurg2006;54:489–92.
30. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, Asada N, Abe S, Isu K, Sugita T, Tomita K. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J ClinOncol2002;20:3470–7.
31. Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jűrgens H, Gadner H, Bielack SS. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J ClinOncol2003;21:2011–8.
32. Suzuki M, Iwata T, Ando S, Iida T, Nakajima T, Ishii T, Yonemoto T, TatezakiS, Fujisawa T, Kimura H. Predictors of long-term survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas. J CardiovascSurg (Torino) 2006;47:603–8.
Review
For citations:
Starodubtsev A.L., Ragulin Yu.A., Kurilchik A.A., Zubarev A.L., Ivanov V.E., Usachev V.S., Medvedev F.V. LONG-TERM RESULTS OF COMBINED TREATMENT OF METASTASES OF SARCOMA OF THE MUSCULOSKELETAL SYSTEM IN THE LUNGS. Malignant tumours. 2014;(3):48-51. (In Russ.) https://doi.org/10.18027/2224-5057-2014-3-48-51